The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Natural Products in Cancer Therapy: Past, Present and Future
Open accessAbstract
Natural products, with remarkable chemical diversity, have been extensively investigated for their anticancer potential for more than a half-century. The collective efforts of the community have achieved the tremendous advancements, bringing natural products to clinical use and discovering new therapeutic opportunities, yet the challenges remain ahead. With remarkable changes in the landscape of cancer therapy and growing role of cutting-edge technologies, we may have come to a crossroads to revisit the strategies to understand nature products and to explore their therapeutic utility. This review summarizes the key advancements in nature product-centered cancer research and calls for the implementation of systematic approaches, new pharmacological models, and exploration of emerging directions to revitalize natural products search in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
Newman, D. J., & Cragg, G. M. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b01285 · Cited by 7,015
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Strategies and challenges for the next generation of antibody–drug conjugates
Beck, A., Goetsch, L., Dumontet, C., & Corvaïa, N. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.268 · Cited by 2,271
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M.-C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 847
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X.-W., Yan, X.-J., Zhou, Z.-R., Yang, F.-F., Wu, Z.-Y., Sun, H.-B., Liang, W.-X., Song, A.-X., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 734
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Sanz, M. A., Fenaux, P., Tallman, M. S., Estey, E. H., Löwenberg, B., Naoe, T., Lengfelder, E., Döhner, H., Burnett, A. K., Chen, S.-J., et al. (2019) · Blood · doi:10.1182/blood-2019-01-894980 · Cited by 664
Niu, C., Yan, H., Yu, T., Sun, H.-P., Liu, J.-X., Li, X.-S., Wu, W., Zhang, F.-Q., Chen, Y., Zhou, L., et al. (1999) · Blood · doi:10.1182/blood.v94.10.3315.422k16_3315_3324 · Cited by 625
Shen, Z.-X., Shi, Z.-Z., Fang, J., Gu, B.-W., Li, J.-M., Zhu, Y.-M., Shi, J.-Y., Zheng, P.-Z., Yan, H., Liu, Y.-F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400053101 · Cited by 583
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
de Thé, H., & Chen, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2943 · Cited by 488
Microbiome and Anticancer Immunosurveillance
Zitvogel, L., Ayyoub, M., Routy, B., & Kroemer, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.001 · Cited by 478
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
Spradlin, J. N., Hu, X., Ward, C. C., Brittain, S. M., Jones, M. D., Ou, L., To, M., Proudfoot, A., Ornelas, E., Woldegiorgis, M., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0304-8 · Cited by 432
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
Swinney, D. C. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.236 · Cited by 413
Chemical proteomics approaches for identifying the cellular targets of natural products
Wright, M. H., & Sieber, S. A. (2016) · Natural Product Reports · doi:10.1039/c6np00001k · Cited by 391
Powell, B. L., Moser, B., Stock, W., Gallagher, R. E., Willman, C. L., Stone, R. M., Rowe, J. M., Coutre, S., Feusner, J. H., Gregory, J., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269621 · Cited by 382
Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
Wall, M. E., & Wani, M. C. (1995) · PubMed · Cited by 376
Camptothecin and Taxol: Historic Achievements in Natural Products Research
Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353
Protein kinase C controls lysosome biogenesis independently of mTORC1
Li, Y., Xu, M., Ding, X., Yan, C., Song, Z., Chen, L., Huang, X., Wang, X., Jian, Y., Tang, G., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3407 · Cited by 353
The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
Lam, W., Bussom, S., Guan, F., Jiang, Z., Zhang, W., Gullen, E. A., Liu, S.-H., & Cheng, Y.-C. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001270 · Cited by 344
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Jeanne, M., Lallemand-Breitenbach, V., Ferhi, O., Koken, M., Le Bras, M., Duffort, S., Peres, L., Berthier, C., Soilihi, H., Raught, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.003 · Cited by 335
Camptothecin and taxol: Discovery to clinic
Wall, M. E. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<299::aid-med2>3.0.co;2-o · Cited by 330
The long story of camptothecin: From traditional medicine to drugs
Martino, E., Della Volpe, S., Terribile, E., Benetti, E., Sakaj, M., Centamore, A., Sala, A., & Collina, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.12.085 · Cited by 296
Maturing antibody–drug conjugate pipeline hits 30
Mullard, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4009 · Cited by 295
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Germano, G., Frapolli, R., Simone, M., Tavecchio, M., Erba, E., Pesce, S., Pasqualini, F., Grosso, F., Sanfilippo, R., Casali, P. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2335 · Cited by 267
Camptothecin and taxol: from discovery to clinic
Wall, M. E., & Wani, M. C. (1996) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01367-9 · Cited by 264
Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
Abdollahpour‐Alitappeh, M., Lotfinia, M., Gharibi, T., Mardaneh, J., Farhadihosseinabadi, B., Larki, P., Faghfourian, B., Sepehr, K. S., Abbaszadeh‐Goudarzi, K., Abbaszadeh‐Goudarzi, G., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27419 · Cited by 249
Chen, S.-J., Zhou, G.-B., Zhang, X.-W., Mao, J.-H., de Thé, H., & Chen, Z. (2011) · Blood · doi:10.1182/blood-2010-11-283598 · Cited by 183
Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
Du, W., & Elemento, O. (2015) · Oncogene · doi:10.1038/onc.2014.291 · Cited by 182
Yang, Y., Sun, M., Yao, W., Wang, F., Li, X., Wang, W., Li, J., Gao, Z., Qiu, L., You, R., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000317 · Cited by 175
Chang, J., Kim, Y., & Kwon, H. J. (2016) · Natural Product Reports · doi:10.1039/c5np00107b · Cited by 162
Curing APL through PML/RARA degradation by As2O3
Lallemand-Breitenbach, V., Zhu, J., Chen, Z., & de Thé, H. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.10.001 · Cited by 148
Gao, C., Hou, G., Liu, J., Ru, T., Xu, Y., Zhao, S., Ye, H., Zhang, L., Chen, K., Guo, Y., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201912489 · Cited by 143
“Omics” in pharmaceutical research: overview, applications, challenges, and future perspectives
Yan, S., Liu, R., Jin, H., Liu, X., Ye, J., Shan, L., & Zhang, W. (2015) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(15)60002-4 · Cited by 129
Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products
Grossman, E. A., Ward, C. C., Spradlin, J. N., Bateman, L. A., Huffman, T. R., Miyamoto, D. K., Kleinman, J. I., & Nomura, D. K. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.013 · Cited by 121
Anticancer drug discovery from Chinese medicinal herbs
Huang, M., Zhang, L., Ding, J., & Lu, J. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0192-y · Cited by 117
Self-citationTarget identification of natural products and bioactive compounds using affinity-based probes
Pan, S., Zhang, H., Wang, C., Yao, S. C. L., & Yao, S. Q. (2015) · Natural Product Reports · doi:10.1039/c5np00101c · Cited by 111
Huang, M., Gao, H., Chen, Y., Zhu, H., Cai, Y., Zhang, X., Miao, Z., Jiang, H., Zhang, J., Shen, H., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1277 · Cited by 107
Self-citationIcaritin promotes tumor T‐cell infiltration and induces antitumor immunity in mice
Hao, H., Zhang, Q., Zhu, H., Wen, Y., Qiu, D., Xiong, J., Fu, X., Wu, Y., Meng, K., & Li, J. (2019) · European Journal of Immunology · doi:10.1002/eji.201948225 · Cited by 98
Machine learning approaches for elucidating the biological effects of natural products
Zhang, R., Li, X., Zhang, X., Qin, H., & Xiao, W. (2020) · Natural Product Reports · doi:10.1039/d0np00043d · Cited by 96
Lin, L., Xie, H., Li, H., Tong, L., Tang, C., Ke, C., Liu, Q., Lin, L., Geng, M., Jiang, H., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701501x · Cited by 92
Self-citationLi, M.-H., Miao, Z., Tan, W., Yue, J., Zhang, C., Lin, L., Zhang, X., & Ding, J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0951 · Cited by 90
Self-citationArtificial Intelligence in Drug Discovery: Into the Great Wide Open
Bajorath, J., Kearnes, S. M., Walters, W. P., Meanwell, N. A., Georg, G. I., & Wang, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01077 · Cited by 65
Target Identification of Bioactive Covalently Acting Natural Products
Nomura, D. K., & Maimone, T. J. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_121 · Cited by 54
Huang, R.-Y., Chen, W., Kurtán, T., Mándi, A., Ding, J., Li, J. X., Li, X., & Guo, Y. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.169 · Cited by 48
Self-citationRole of Gut Microbiota in the Pharmacological Effects of Natural Products
Pan, C., Qing-long, G., & Lu, N. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2682748 · Cited by 42
Zhu, X., Yuan, C., Tian, C., Li, C., Nie, F., Song, X., Zeng, R., Wu, D., Hao, X., & Li, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.819300 · Cited by 39
Quantitative Chemical Proteomic Profiling of thein VivoTargets of Reactive Drug Metabolites
Whitby, L. R., Obach, R. S., Simon, G. M., Hayward, M. M., & Cravatt, B. F. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00346 · Cited by 38
Yu, B., Li, M.-H., Wang, W., Wang, Y.-Q., Jiang, Y., Yang, S., Yue, J., Ding, J., & Miao, Z. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0865-4 · Cited by 25
Self-citation
Cited by
Elshafie, H. S., Camele, I., & Mohamed, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043266 · Cited by 439
Zhu, Y., Ouyang, Z., Du, H., Wang, M., Wang, J., Sun, H., Kong, L., Xu, Q., Ma, H., & Sun, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.022 · Cited by 414
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Abdul-Aziz Ahmed, K., Jabbar, A. A. J., Abdulla, M. A., Zuhair Alamri, Z., Ain Salehen, N., Abdel Aziz Ibrahim, I., Almaimani, G., Bamagous, G. A., Almaimani, R. A., Almasmoum, H. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50947-y · Cited by 26
Zhang, C., Chen, W., Dong, T., Wang, Y., Yao, M., Xiao, W., & Li, B. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1141272 · Cited by 16
Metadata
- Authors
- Huang, M., Lu, J.-J., & Ding, J.
- Venue
- Natural Products and Bioprospecting
- Published
- 2021-01-03
- Volume
- 11
- Issue
- 1
- Pages
- 5-13
- ISSN
- 2192-2195 (ISSN-L)
- 2192-2209
- OpenAlex
- W3119787068
- Cited by
- 648
- References
- 52
- FWCI
- 27.71
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.